Literature DB >> 10750620

Antibodies to human herpes virus type 8 (HHV8) in general population and in individuals at risk for sexually transmitted diseases in Western Sicily.

A M Perna1, F Bonura, F Vitale, E Viviano, M A Di Benedetto, F Ajello, M R Villafrate, T Prestileo, S Mancuso, J J Goedert, N Romano.   

Abstract

BACKGROUND: Human herpes virus 8 (HHV8) appears to be the primary aetiologic agent of Kaposi sarcoma (KS). To study the distribution of HHV8, a seroepidemiological study was carried out in western Sicily, where a high incidence rate of classical KS is well documented.
METHODS: A total of 970 sera of healthy human immunodeficiency virus (HIV) negative individuals of general population (1-70 years old) and 742 sera of individuals in different risk groups for HIV infection were evaluated by means of an indirect immunofluorescence assay able to detect antibodies to lytic and latent HHV8 antigens.
RESULTS: Crude seroprevalence to HHV8 antigens was 11.5% in the general population, and it increased significantly with age from 6% under age 16 to 22% after age 50. Significantly higher HHV8 seroprevalence rates were detected among HIV positive and negative homosexual men (62% and 22%, respectively), men who had sex with prostitutes (40% and 29%, respectively); female prostitutes (42% and 30%, respectively), and clients at a sexually transmitted disease clinic (male: 60% and 33%, respectively, female: 63% and 43%, respectively). In contrast, heterosexual intravenous drug users had seroprevalence rates comparable to those found in the general population.
CONCLUSIONS: The results suggest that HHV8 infection is widespread in Western Sicily. The high seroprevalence in individuals with high risk sexual activity point to the role of sexual behaviour in the transmission of the infection in adults, whereas the detection of antibodies in younger population (under 16 years old) is suggestive of a non-sexual route of transmission, probably occurring during childhood by close personal contact.

Entities:  

Mesh:

Year:  2000        PMID: 10750620     DOI: 10.1093/ije/29.1.175

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  10 in total

1.  HHV8 a subtype is associated with rapidly evolving classic Kaposi's sarcoma.

Authors:  Roberta Mancuso; Renato Biffi; Marilena Valli; Monica Bellinvia; Athanasia Tourlaki; Tourlaki Athanasia; Silvia Ferrucci; Lucia Brambilla; Serena Delbue; Pasquale Ferrante; Carmine Tinelli; Mario Clerici
Journal:  J Med Virol       Date:  2008-12       Impact factor: 2.327

2.  Gender differences in Kaposi's sarcoma-associated herpesvirus infection in a population with schistosomiasis in rural China.

Authors:  Bishi Fu; Rongge Yang; Fan Xia; Baolin Li; Xinxing Ouyang; Shou-Jiang Gao; Linding Wang
Journal:  Jpn J Infect Dis       Date:  2012-07       Impact factor: 1.362

Review 3.  Prevalence of Kaposi's sarcoma-associated herpesvirus among intravenous drug users: a systematic review and meta-analysis.

Authors:  Qiwen Fang; Zhenqiu Liu; Zhijie Zhang; Yan Zeng; Tiejun Zhang
Journal:  Virol Sin       Date:  2017-10-13       Impact factor: 4.327

4.  Establishment of an ELISA to detect Kaposi's sarcoma-associated herpesvirus using recombinant ORF73.

Authors:  Xin-xing Ouyang; Bi-shi Fu; Bao-lin Li; Yan Zeng; Fan-hong Xu; Lin-ding Wang
Journal:  Virol Sin       Date:  2010-06-06       Impact factor: 4.327

Review 5.  Is human herpesvirus 8 infection more common in men than in women? Systematic review and meta-analysis.

Authors:  Lorin Begré; Eliane Rohner; Sam M Mbulaiteye; Matthias Egger; Julia Bohlius
Journal:  Int J Cancer       Date:  2016-04-26       Impact factor: 7.396

6.  A seroprevalence study of human herpesvirus type 8 (HHV8) in eastern and Central Africa and in the Mediterranean area.

Authors:  D Serraino; L Toma; M Andreoni; S Buttò; O Tchangmena; L Sarmati; P Monini; S Franceschi; B Ensoli; G Rezza
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

7.  Risk factors for classical Kaposi sarcoma in a population-based case-control study in Sicily.

Authors:  Lesley A Anderson; Carmela Lauria; Nino Romano; Elizabeth E Brown; Denise Whitby; Barry I Graubard; Yan Li; Angelo Messina; Lorenzo Gafà; Francesco Vitale; James J Goedert
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-12       Impact factor: 4.254

8.  Seroprevalence of Kaposi's sarcoma-associated herpesvirus and risk factors in Xinjiang, China.

Authors:  Bishi Fu; Feng Sun; Baolin Li; Lei Yang; Yan Zeng; Xiulian Sun; Fanhong Xu; Simon Rayner; Moraima Guadalupe; Shou-Jiang Gao; Linding Wang
Journal:  J Med Virol       Date:  2009-08       Impact factor: 2.327

Review 9.  Human herpesvirus 8--a novel human pathogen.

Authors:  Daniel C Edelman
Journal:  Virol J       Date:  2005-09-02       Impact factor: 4.099

10.  Classic Kaposi's sarcoma in Italy, 1985-1998.

Authors:  L Dal Maso; J Polesel; V Ascoli; P Zambon; M Budroni; S Ferretti; R Tumino; G Tagliabue; S Patriarca; M Federico; M Vercelli; A Giacomin; G Vicario; F Bellù; F Falcini; E Crocetti; V De Lisi; S Vitarelli; S Piffer; F Stracci; D Serraino; G Rezza; S Franceschi
Journal:  Br J Cancer       Date:  2005-01-17       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.